Literature DB >> 8322893

Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA.

M A Carome1, L J Striker, E P Peten, J Moore, C W Yang, W G Stetler-Stevenson, G E Striker.   

Abstract

Alterations in the balance between synthesis and degradation of extracellular matrix may result in glomerulosclerosis. The interaction between metalloproteinases and their inhibitors presumably modulates the rate of glomerular matrix degradation. We examined the gene expression of tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 in human glomeruli and TIMP-2 protein in tissue sections. Kidney tissue was obtained from adults undergoing nephrectomy for renal tumor (n = 9) or biopsy for nephrosis and renal failure (n = 1). Glomeruli were microdissected and subjected to reverse transcription. TIMP cDNAs were quantitated by competitive polymerase chain reaction assays. Five nephrectomy specimens had normal glomeruli and four had diffuse glomerulosclerosis. TIMP-1 and TIMP-2 cDNA levels, detected in glomeruli from all patients, were increased fourfold and threefold, respectively, in patients with glomerulosclerosis. The elevated TIMP cDNA levels could not be attributed to an increased number of glomerular cells. TIMP-2 protein was detected within normal and sclerotic glomeruli. In conclusion, both TIMP genes were expressed in normal glomeruli, and their level of expression was increased in glomerulosclerosis associated with renal carcinoma, suggesting that expression of these inhibitors may correlate with the development of sclerosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322893     DOI: 10.1152/ajprenal.1993.264.6.F923

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

2.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

3.  Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells.

Authors:  David R Emlet; Nuria Pastor-Soler; Allison Marciszyn; Xiaoyan Wen; Hernando Gomez; William H Humphries; Seth Morrisroe; Jacob K Volpe; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

4.  Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.

Authors:  Sathnur Pushpakumar; Sourav Kundu; Tyranny Pryor; Srikanth Givvimani; Eleanor Lederer; Suresh C Tyagi; Utpal Sen
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

5.  Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.

Authors:  Xuefeng B Ling; Tara K Sigdel; Kenneth Lau; Lihua Ying; Irwin Lau; James Schilling; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

6.  Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.

Authors:  C W Yang; H Vlassara; E P Peten; C J He; G E Striker; L J Striker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

8.  Effect of oral camostat mesilate on hematuria and/or proteinuria in children.

Authors:  Tadashi Asami; Shuichi Tomisawa; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2004-01-23       Impact factor: 3.714

Review 9.  Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

10.  Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure.

Authors:  Lei Wang; Jue Wang; Yong Wang; Qiang Fu; Yong-Hua Lei; Zhi-Yong Nie; Jianxin Qiu; Ting-Yi Bao
Journal:  Exp Ther Med       Date:  2013-11-15       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.